Adjuvant Radiation after Primary Resection of Atypical Lipomatous Tumors of the Extremity Reduces Local Recurrence but Increases Complications: A Multicenter Evaluation.

Q2 Medicine
Sarcoma Pub Date : 2022-08-22 eCollection Date: 2022-01-01 DOI:10.1155/2022/2091677
Joshua M Lawrenz, Samuel R Johnson, Kevin Zhu, Mallory McKeon, Cullen P Moran, Jose Vega, Katherine S Hajdu, James P Norris, Leo Y Luo, Eric T Shinohara, Justin M M Cates, Brian P Rubin, John D Reith, Jennifer L Halpern, Nathan W Mesko, Herbert S Schwartz, Lukas M Nystrom, Ginger E Holt
{"title":"Adjuvant Radiation after Primary Resection of Atypical Lipomatous Tumors of the Extremity Reduces Local Recurrence but Increases Complications: A Multicenter Evaluation.","authors":"Joshua M Lawrenz,&nbsp;Samuel R Johnson,&nbsp;Kevin Zhu,&nbsp;Mallory McKeon,&nbsp;Cullen P Moran,&nbsp;Jose Vega,&nbsp;Katherine S Hajdu,&nbsp;James P Norris,&nbsp;Leo Y Luo,&nbsp;Eric T Shinohara,&nbsp;Justin M M Cates,&nbsp;Brian P Rubin,&nbsp;John D Reith,&nbsp;Jennifer L Halpern,&nbsp;Nathan W Mesko,&nbsp;Herbert S Schwartz,&nbsp;Lukas M Nystrom,&nbsp;Ginger E Holt","doi":"10.1155/2022/2091677","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Radiation after resection of an atypical lipomatous tumor (ALT) is controversial. This study evaluates local control and complications after the first resection of ALTs of the extremity with or without adjuvant radiation.</p><p><strong>Methods: </strong>A dual institution, retrospective review of patients treated from 1995 to 2020 with first-time resection of an ALT in the extremity was performed. In total, 102 patients underwent adjuvant radiation (XRT group) and 68 patients were treated with surgery alone (no-XRT group). The median follow-up time was 4.6 years (interquartile range (IQR) 2.0-7.3 years). The median radiation dose was 60 Gy (IQR 55-66 Gy). Univariable and multivariable analyses evaluated the association of patient, tumor, and treatment variables with recurrence and complications. Kaplan-Meier analysis evaluated local recurrence-free survival (LRFS) and time to complication.</p><p><strong>Results: </strong>The overall incidence of local recurrence was 1% (1/102) in the XRT group and 24% (16/68) in the no-XRT group (<i>p</i> < 0.001). The median time-to-recurrence was 8.2 years (IQR 6.5-10.5 years). In the XRT and the no-XRT groups, 5-yr LRFS was 98% and 92% (<i>p</i>=0.21) and 10-yr LRFS was 98% and 41% (<i>p</i> < 0.001), respectively. The absence of radiation (HR = 23.63, 95% CI (3.09-180.48); <i>p</i> < 0.001) and R2 surgical resection margins (HR = 11.04, 95% CI (2.07-59.03); <i>p</i> < 0.001) incurred a 23-fold and 11-fold increased risk of local recurrence, respectively, while tumor size, depth, location, and neurovascular involvement were not found to be independent predictors of recurrence. The complication rate was 37% (38/102) in the XRT group and 10% (7/68) in the no-XRT group (<i>p</i> < 0.001). Eight patients (8/102, 8%) required surgical management for complication in the XRT group compared with two patients (2/68, 3%) in the no-XRT group (<i>p</i>=0.10). Higher radiation dose had a modest correlation with increased severity of complication (<i>ρ</i>=0.24; <i>p</i>=0.02).</p><p><strong>Conclusions: </strong>Adjuvant radiation after first-time resection of an ALT of the extremity was associated with a significantly reduced risk of local recurrence but a three-fold increase in complication rate. These data support a 10-year follow-up for these patients and inform a notable clinical trade-off if considering adjuvant radiation for this tumor with recurrent potential.</p>","PeriodicalId":21431,"journal":{"name":"Sarcoma","volume":" ","pages":"2091677"},"PeriodicalIF":0.0000,"publicationDate":"2022-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424010/pdf/","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sarcoma","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2022/2091677","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 3

Abstract

Background: Radiation after resection of an atypical lipomatous tumor (ALT) is controversial. This study evaluates local control and complications after the first resection of ALTs of the extremity with or without adjuvant radiation.

Methods: A dual institution, retrospective review of patients treated from 1995 to 2020 with first-time resection of an ALT in the extremity was performed. In total, 102 patients underwent adjuvant radiation (XRT group) and 68 patients were treated with surgery alone (no-XRT group). The median follow-up time was 4.6 years (interquartile range (IQR) 2.0-7.3 years). The median radiation dose was 60 Gy (IQR 55-66 Gy). Univariable and multivariable analyses evaluated the association of patient, tumor, and treatment variables with recurrence and complications. Kaplan-Meier analysis evaluated local recurrence-free survival (LRFS) and time to complication.

Results: The overall incidence of local recurrence was 1% (1/102) in the XRT group and 24% (16/68) in the no-XRT group (p < 0.001). The median time-to-recurrence was 8.2 years (IQR 6.5-10.5 years). In the XRT and the no-XRT groups, 5-yr LRFS was 98% and 92% (p=0.21) and 10-yr LRFS was 98% and 41% (p < 0.001), respectively. The absence of radiation (HR = 23.63, 95% CI (3.09-180.48); p < 0.001) and R2 surgical resection margins (HR = 11.04, 95% CI (2.07-59.03); p < 0.001) incurred a 23-fold and 11-fold increased risk of local recurrence, respectively, while tumor size, depth, location, and neurovascular involvement were not found to be independent predictors of recurrence. The complication rate was 37% (38/102) in the XRT group and 10% (7/68) in the no-XRT group (p < 0.001). Eight patients (8/102, 8%) required surgical management for complication in the XRT group compared with two patients (2/68, 3%) in the no-XRT group (p=0.10). Higher radiation dose had a modest correlation with increased severity of complication (ρ=0.24; p=0.02).

Conclusions: Adjuvant radiation after first-time resection of an ALT of the extremity was associated with a significantly reduced risk of local recurrence but a three-fold increase in complication rate. These data support a 10-year follow-up for these patients and inform a notable clinical trade-off if considering adjuvant radiation for this tumor with recurrent potential.

Abstract Image

Abstract Image

Abstract Image

肢体非典型脂肪瘤初次切除后的辅助放疗减少了局部复发,但增加了并发症:一项多中心评估。
背景:非典型脂肪瘤(ALT)切除术后的放疗是有争议的。本研究评估首次切除肢体ALTs后的局部控制和并发症,有或没有辅助放疗。方法:对1995年至2020年首次切除肢体ALT的双机构患者进行回顾性分析。102例患者接受辅助放疗(XRT组),68例患者单独接受手术治疗(无XRT组)。中位随访时间为4.6年(四分位间距(IQR) 2.0 ~ 7.3年)。中位辐射剂量为60 Gy (IQR 55 ~ 66 Gy)。单变量和多变量分析评估了患者、肿瘤和治疗变量与复发和并发症的关系。Kaplan-Meier分析评估局部无复发生存期(LRFS)和并发症发生时间。结果:XRT组总局部复发率为1%(1/102),未XRT组总局部复发率为24% (16/68)(p < 0.001)。中位复发时间为8.2年(IQR为6.5-10.5年)。在XRT组和非XRT组中,5年LRFS分别为98%和92% (p=0.21), 10年LRFS分别为98%和41% (p < 0.001)。无辐射(HR = 23.63, 95% CI (3.09-180.48);p < 0.001)和R2手术切除边缘(HR = 11.04, 95% CI (2.07-59.03);P < 0.001)分别增加了23倍和11倍的局部复发风险,而肿瘤大小、深度、位置和神经血管受累并不是复发的独立预测因素。XRT组并发症发生率为37%(38/102),无XRT组并发症发生率为10%(7/68),差异有统计学意义(p < 0.001)。XRT组有8例患者(8/ 102,8%)因并发症需要手术治疗,而非XRT组有2例患者(2/ 68,3%)(p=0.10)。较高的辐射剂量与并发症严重程度的增加有适度的相关性(ρ=0.24;p = 0.02)。结论:首次切除肢体ALT后的辅助放疗与局部复发风险显著降低相关,但并发症发生率增加三倍。这些数据支持对这些患者进行10年随访,并告知如果考虑对有复发潜力的肿瘤进行辅助放疗,需要进行显著的临床权衡。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Sarcoma
Sarcoma Medicine-Radiology, Nuclear Medicine and Imaging
CiteScore
5.00
自引率
0.00%
发文量
15
审稿时长
14 weeks
期刊介绍: Sarcoma is dedicated to publishing papers covering all aspects of connective tissue oncology research. It brings together work from scientists and clinicians carrying out a broad range of research in this field, including the basic sciences, molecular biology and pathology and the clinical sciences of epidemiology, surgery, radiotherapy and chemotherapy. High-quality papers concerning the entire range of bone and soft tissue sarcomas in both adults and children, including Kaposi"s sarcoma, are published as well as preclinical and animal studies. This journal provides a central forum for the description of advances in diagnosis, assessment and treatment of this rarely seen, but often mismanaged, group of patients.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信